Testing effectiveness (Phase 2)Not Yet RecruitingNCT07325201
What this trial is testing
Mitigating DKA in Type 1 Diabetes for Safe Use of SGLT Inhibitors Using Dual Continuous Ketone and Glucose Monitoring.
Who this might be right for
Type 1 Diabetes MellitusChronic Kidney Disease (CKD) With Diabetes Mellitus (DM)Chronic Kidney Disease+2 more
HealthPartners Institute 80